Border to Coast Pensions Partnership Ltd Purchases 47,220 Shares of Thermo Fisher Scientific Inc. $TMO

Key Points

• Border to Coast Pensions Partnership Ltd increased its holdings in Thermo Fisher Scientific by 50.3% in Q2, owning 141,133 shares worth approximately $57.2 million at the end of the reporting period.
• Analysts have recently boosted their price targets for Thermo Fisher Scientific, with an average target of $588.35, reflecting a consensus rating of "Moderate Buy."
• The company announced a quarterly dividend of $0.43, which will be paid to investors on October 15, 2023, representing a 0.4% dividend yield.

Border to Coast Pensions Partnership Ltd grew its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 50.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 141,133 shares of the medical research company's stock after purchasing an additional 47,220 shares during the quarter. Border to Coast Pensions Partnership Ltd's holdings in Thermo Fisher Scientific were worth $57,224,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Bernard Wealth Management Corp. purchased a new position in Thermo Fisher Scientific in the fourth quarter valued at approximately $25,000. CBIZ Investment Advisory Services LLC raised its position in Thermo Fisher Scientific by 137.5% during the 1st quarter. CBIZ Investment Advisory Services LLC now owns 57 shares of the medical research company's stock valued at $28,000 after purchasing an additional 33 shares in the last quarter. Ameriflex Group Inc. acquired a new stake in Thermo Fisher Scientific in the 4th quarter valued at $30,000. Anderson Financial Strategies LLC acquired a new stake in shares of Thermo Fisher Scientific during the first quarter worth about $30,000. Finally, Keystone Global Partners LLC acquired a new position in Thermo Fisher Scientific during the first quarter worth $31,000. 89.23% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on TMO shares. Hsbc Global Res lowered Thermo Fisher Scientific from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 24th. Wall Street Zen lowered Thermo Fisher Scientific from a "buy" rating to a "hold" rating in a research note on Sunday, September 7th. William Blair started coverage on shares of Thermo Fisher Scientific in a research note on Monday, August 18th. They issued an "outperform" rating for the company. UBS Group boosted their target price on Thermo Fisher Scientific from $460.00 to $500.00 and gave the stock a "neutral" rating in a research report on Thursday, July 24th. Finally, Wells Fargo & Company dropped their price objective on Thermo Fisher Scientific from $570.00 to $565.00 and set an "overweight" rating for the company in a research note on Thursday, July 24th. Sixteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Thermo Fisher Scientific has an average rating of "Moderate Buy" and an average price target of $588.35.

Insider Buying and Selling at Thermo Fisher Scientific

In other news, EVP Gianluca Pettiti sold 400 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $479.98, for a total value of $191,992.00. Following the transaction, the executive vice president directly owned 22,367 shares of the company's stock, valued at $10,735,712.66. This represents a 1.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Joseph R. Holmes sold 385 shares of the business's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $492.63, for a total transaction of $189,662.55. Following the sale, the chief accounting officer directly owned 2,319 shares in the company, valued at approximately $1,142,408.97. The trade was a 14.24% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,066 shares of company stock worth $14,182,963. Corporate insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Trading Down 0.2%

Thermo Fisher Scientific stock traded down $1.08 during midday trading on Friday, hitting $480.02. 4,241,401 shares of the stock were exchanged, compared to its average volume of 1,557,193. The stock's 50-day simple moving average is $472.01 and its 200 day simple moving average is $448.95. The stock has a market capitalization of $181.26 billion, a price-to-earnings ratio of 27.76, a PEG ratio of 2.56 and a beta of 0.75. Thermo Fisher Scientific Inc. has a fifty-two week low of $385.46 and a fifty-two week high of $623.77. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.22 by $0.14. The firm had revenue of $10.86 billion during the quarter, compared to the consensus estimate of $10.68 billion. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The firm's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.37 EPS. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. On average, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be paid a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is 9.95%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.